An observational study of vascular endothelial growth factor inhibitors as second-line treatment for metastatic colorectal cancer treated with bevacizumab plus FOLFIRI beyond progression: the association with RAS mutation and tumor sidedness

DOI: 10.21037/32576

Full-Text   Cite this paper   Add to My Lib

Abstract:

Curative surgical resection is a treatment for initial colorectal cancer (CRC) (1). If resection is unfeasible, then chemotherapy or target therapy is used to prolong life expectancy

Full-Text